Education
Health
Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging
Mumbai (Maharashtra) [India], October 28: An unexplained femoral fracture in an eight-year-old Golden Retriever named Waffle led to the discovery of a potentially life-threatening, widespread bone tumour at Fredna Vet Diagnostics, highlighting the role of advanced imaging in identifying serious underlying disease in companion animals.
Waffle was presented with severe right hindlimb lameness that had progressed to complete non-weight-bearing, despite no known history of trauma. Initial radiographs revealed a fracture of the right femur with aggressive bone destruction, raising suspicion of an underlying pathological process. Preliminary investigations, including routine blood tests and abdominal ultrasonography, did not establish the cause.
A subsequent whole-body, contrast-enhanced CT examination revealed an extensive destructive lesion in the proximal femur, along with additional bone lesions involving the scapula, ribs and vertebrae. Lesions in the liver and spleen were also suggestive of metastatic involvement. The findings strongly supported advanced, multifocal osteosarcoma, an aggressive form of bone cancer, although definitive confirmation would require histopathological examination. No pulmonary metastases were identified on the CT scan.
3D reconstruction image showing multiple fracture fragments
Commenting on the case, Dr. Chetanya Walia, Veterinary Radiologist, Fredna Vet Diagnostics, said, “When a fracture occurs without any identifiable trauma, it is important to look beyond the injury itself. In Waffle’s case, whole-body CT helped us identify the extent of the bone destruction and detect additional lesions that were not established through the initial investigations. This highlights how advanced imaging can play a critical role in evaluating complex cases and guiding further clinical decisions.”
The case demonstrates how advanced CT imaging can reveal the extent of disease beyond the site of an apparent orthopaedic injury, supporting a more comprehensive assessment of complex conditions.
Fredna Vet Diagnostics also offers specialised veterinary cone-beam computed tomography (CBCT), extending advanced three-dimensional imaging capabilities into animal healthcare. While conventional CT was used in Waffle’s case, the centre’s specialised imaging capabilities reflect the growing role of advanced diagnostics in veterinary medicine.
About Fredna Vet Diagnostics
Fredna Vet Diagnostics provides specialised diagnostic imaging services for companion animals, supporting veterinary professionals in investigating complex clinical conditions.
Business
Vedant Poly Fabs Limited is engaged in the manufacturing of flexible packaging materials for businesses
Company’s IPO will open on November 2, 2026 and close on November 4, 2026
New Delhi [India], October 31: West Bengal-based Vedant Poly Fabs Limited is engaged in the manufacturing of flexible packaging materials for businesses. The company is launching its IPO on the NSE Emerge platform to finance additional requirements, fully or partially repay certain outstanding secured and/or unsecured loans, finance capital expenditure for the purchase and installation of plant and machinery at its existing manufacturing facility, and meet general corporate purposes.
Business activities: Vedant Poly Fabs Limited was incorporated in December 2018. The company is engaged in manufacturing flexible packaging materials for businesses across India. It operates as a business-to-business supplier and offers a diverse range of packaging products, including 3-layer and 5-layer LD films, shrink films, barrier films, printed laminates, and milk and oil pouches, catering to the requirements of industries such as food and beverages and other consumer goods.
Financial performance: According to the balance sheet, the company recorded total revenue of Rs. 4,972.92 lakh and profit after tax of Rs. 63.59 lakh in FY 2024. In FY 2025, the company recorded total revenue of Rs. 8,157.97 lakh and profit after tax of Rs. 456.06 lakh. In FY 2026, the company generated total revenue of Rs. 11,531.47 lakh and profit after tax of Rs. 1,096.62 lakh. In the first quarter of FY 2027, the company recorded total revenue of Rs. 3,049.16 lakh and profit after tax of Rs. 347.81 lakh.
In the first quarter of FY 2027, the company achieved a profit-after-tax margin of approximately 11.48%.
IPO details: The IPO of Vedant Poly Fabs Limited will open on November 2, 2026 and close on November 4, 2026, on the NSE Emerge platform. Through the book-built issue, the company is issuing 60,30,000 equity shares with a face value of Rs. 10 each at a price band of Rs. 88 to Rs. 94 per share. The total issue size is Rs. 56.6820 crore, of which Rs. 5.6738 crore will be raised through an offer for sale (OFS) by existing shareholders. The market lot size of the IPO is 1,200 shares, and retail investors will have to apply for two lots. The IPO is being managed by the lead manager, Affinity Global Capital Market Private Limited.
Note: This article is not investment advice.
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.